POU5F1 expression

Chronic HG promoted stem-like and radioresistant phenotypes in NSCLC cells. Prolonged HBO exposure for 4 weeks attenuated these effects and was associated with reduced HIF-1α, SOX2, and OCT4 expression, supporting HBO as a potential preclinical adjunct strategy for mitigating HG-associated therapeutic resistance.

Consistent with previous reports of increased senescence, our findings demonstrate significant downregulation of stemness-related genes (NANOG, OCT4) in MSCs from newly diagnosed, untreated patients with MM. This concurrent dysregulation of stemness and increased senescent phenotype may contribute to the pathogenicity of the tumor microenvironment and represents a potential target for therapeutic intervention.

The stability of BACH1 mRNA following actinomycin D (ActD) treatment was analyzed after YTHDC1 silencing...Collectively, YTHDC1 regulates BACH1 expression in an m6A-dependent mechanism, contributing to TNBC progression. Implications: Our findings provide a rationale for further investigation of the YTHDC1/BACH1 axis as a potential therapeutic target in TNBC.

Taken together, the hMPEC and mice in situ models were constructed by our team for the first time, wherein DHA@ZIF-8 exhibits potent chemotherapeutic efficacy in these models. DHA@ZIF-8 facilitates M1 polarization of macrophages through the depression of the OCT4/NF-κB/M-CSF signaling pathway to enhance immunotherapeutic efficacy simultaneously, which provides a critical basis for DHA and bionanomaterial application in MPE treatment in the future.

This OSK-induced priming overcomes the cytokinesis barrier in proliferating CMs both in vitro and in vivo, yielding mononuclear CMs with high proliferative potential and ultimately enhancing cardiac repair after MI. Our findings reveal that OSK promotes regeneration primarily by priming dedifferentiation and overcoming cytokinesis bottlenecks, rather than by directly inducing CM S-phase entry, and establish OSK as a novel, safer reprogramming-based strategy for the treatment of MI.

Assessment of transcription factors involved in the induction and maintenance of EC and YST phenotypes suggests that, in pure non-seminomas, reprogramming occurs outside the spermatogonial niche.

The PDE5 inhibitor sildenafil might be repurposed to be a possible therapeutic option for treating cervical cancer. Its efficacy extends to both HPV-positivity and CSCs, addressing a significant portion of cervical cancer cases.

Blue light irradiation reduced viability and migration in both OSCC cell lines and induced apoptosis only in non-metastatic SCC9 cells. Blue light exerted anti-tumor effects without promoting cancer stem cells properties, while decreasing their ability to self-renew.

OCT4 expression is a specific biomarker for PDAC. Its increased expression signified PDAC progression and CD24 activation in a subset of PDAC. KRAS mutants have lower OCT4 expression, suggesting an alternative mechanism for cancer progression than that in OCT4 positive PDAC.

OCT4, HER2, and ezrin in CTCs were also predictors of poor prognosis and treatment response, but the data is limited. If explored further, microRNAs could serve as a potential alternative to circulating tumor cells, as they are - in theory - able to perform the same functions.

Our findings reveal that ABE effectively overcomes 5-FU resistance in CRC by targeting the TLR3/NF-κB signaling axis. This study highlights ABE as a safe, accessible, and promising adjunctive strategy to enhance therapeutic responses in 5-FU-resistant CRC.

In addition to technical validation, we describe a practical approach to optimize the manufacturing workflow to improve operational efficiency within clinical environments. These included predefined process pauses to manage personnel and expiration-prone materials, thereby enhancing the feasibility and reproducibility of iPSC manufacturing in real-world GMP-compliant work environments.